Back to Search
ANNA DURBIN, M.D.
M.D.
Infectious Disease Physician
NPI: 1326089541Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
D46654(MD)
Research & Publications (20)
Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever.
PMID 18452966·Virology·2008
8-other
rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers.
PMID 15688284·J Infect Dis·2005
3-trial
Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines.
PMID 14689350·Clin Infect Dis·2003
8-other
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.
PMID 11716091·Am J Trop Med Hyg·2001
7-preclinical
JNK1 determines the oncogenic or tumor-suppressive activity of the integrin-linked kinase in human rhabdomyosarcoma.
PMID 19478459·J Clin Invest·2009
7-preclinical
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals.
PMID 19410624·Vaccine·2009
3-trial
The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals.
PMID 19234231·J Immunol·2009
7-preclinical
Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity.
PMID 18981503·Am J Trop Med Hyg·2008
3-trial
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.
PMID 18612426·PLoS One·2008
3-trial
Antigenic relationships between sylvatic and endemic dengue viruses.
PMID 18606776·Am J Trop Med Hyg·2008
7-preclinical
Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization.
PMID 18464894·PLoS Pathog·2008
7-preclinical
The estrogen receptor pathway in rhabdomyosarcoma: a role for estrogen receptor-beta in proliferation and response to the antiestrogen 4'OH-tamoxifen.
PMID 18451176·Cancer Res·2008
8-other
Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers.
PMID 18207289·Vaccine·2008
3-trial
Systemic pharmacokinetics of rifaximin in volunteers with shigellosis.
PMID 18086855·Antimicrob Agents Chemother·2008
3-trial
The CXCR4-SDF1alpha axis is a critical mediator of rhabdomyosarcoma metastatic signaling induced by bone marrow stroma.
PMID 17768666·Clin Exp Metastasis·2008
8-other
Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge.
PMID 16586388·Clin Infect Dis·2006
2-rct
Development of a live attenuated dengue virus vaccine using reverse genetics.
PMID 16553547·Viral Immunol·2006
6-review
Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria.
PMID 15908397·Infect Immun·2005
3-trial
Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.
PMID 15837212·Vaccine·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 N WOLFE ST
BALTIMORE, MD 21287 - Phone
- (410) 955-1725
Quick Facts
- NPI
- 1326089541
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile